GlassScriptPhysician profile
Matthew S Johnson
NPI 1962411587
$1,692.67
in general payments reported to CMS, 2019-2025
18 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,055 · 2020: $638.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $286.89 | 2019-2020 | |
| Amarin Pharma, INC. | $230.69 | 2019-2020 | |
| Novo Nordisk INC | $197.60 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $150.85 | 2019 | |
| Janssen Pharmaceuticals, INC | $143.77 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $123.01 | 2019-2020 | |
| Amgen INC. | $105.20 | 2019-2020 | |
| Pfizer INC. | $94.44 | 2019-2020 | |
| Sanofi-Aventis U.S. LLC | $79.83 | 2019-2020 | |
| Jazz Pharmaceuticals INC. | $77.07 | 2019 | |
| Astellas Pharma US INC | $76.82 | 2019-2020 | |
| Kowa Pharmaceuticals America, INC. | $38.43 | 2019-2020 | |
| Allergan, INC. | $22.66 | 2019-2020 | |
| Sanofi Pasteur INC. | $16.22 | 2019 | |
| Corcept Therapeutics | $15.42 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Circassia INC. | $11.74 | 2019 | |
| Glaxosmithkline, LLC. | $11.20 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $10.83 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.